Topical timolol for an iris hemangioma

Ravali Gummi; Erin D Stahl; Justin D Marsh

doi:10.1016/j.jaapos.2017.10.015

Topical timolol for an iris hemangioma

J AAPOS. 2018 Apr;22(2):156-158. doi: 10.1016/j.jaapos.2017.10.015. Epub 2018 Mar 20.

Authors

Ravali Gummi¹, Erin D Stahl², Justin D Marsh³

Affiliations

¹ University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
² University of Missouri-Kansas City School of Medicine, Kansas City, Missouri; Pediatric Ophthalmology, Children's Mercy Hospital, Kansas City, Missouri.
³ University of Missouri-Kansas City School of Medicine, Kansas City, Missouri; Pediatric Ophthalmology, Children's Mercy Hospital, Kansas City, Missouri. Electronic address: jdmarsh@cmh.edu.

PMID: 29412149
DOI: 10.1016/j.jaapos.2017.10.015

Abstract

Extraocular infantile hemangiomas have been shown to respond to oral and topical beta blockers, while there is little literature regarding the management of intraocular infantile hemangiomas with beta blockers. This case report discusses the management of an iris hemangioma with topical timolol, a treatment previously unreported in the literature.

Publication types

Case Reports

MeSH terms

Administration, Ophthalmic
Adrenergic beta-Antagonists / administration & dosage
Adrenergic beta-Antagonists / therapeutic use*
Female
Hemangioma, Capillary / diagnostic imaging
Hemangioma, Capillary / drug therapy*
Humans
Infant
Iris Neoplasms / diagnostic imaging
Iris Neoplasms / drug therapy*
Magnetic Resonance Imaging
Microscopy, Acoustic
Neoplastic Syndromes, Hereditary / diagnostic imaging
Neoplastic Syndromes, Hereditary / drug therapy*
Timolol / administration & dosage
Timolol / therapeutic use*

Substances

Adrenergic beta-Antagonists
Timolol

Supplementary concepts

Hemangioma, capillary infantile